Wang Yizhe 4

What Happened

• Wang Yizhe, an Operating Partner at Zai Lab (ZLAB), received two equity awards on 2026-05-11: a grant covering 136,819 ADS-equivalent derivative awards and a grant of 59,288 Restricted Share Units (RSUs). Both awards were reported at $0.00 (no cash paid at grant) and are derivative awards that vest over time.

Key Details

• Transaction date: 2026-05-11; Form 4 filed: 2026-06-08 (filed late relative to the transaction date).
• Awards: 136,819 (derivative award; per filing subject to vesting) and 59,288 RSUs — total = 196,107 ADS-equivalents.
• Vesting: Both awards vest in equal annual installments over four years beginning 05/11/2027, subject to continuous service (footnotes F2 and F4).
• RSU delivery: Each RSU represents a contingent right to receive one ADS; vested RSUs will be delivered as ADSs (F3, F4).
• ADS conversion: Each ADS represents ten ordinary shares; ADSs and ordinary shares are fully fungible (F1).
• Shares owned after the transaction: Not specified in the filing.
• Filing timeliness: The Form 4 was filed almost a month after the grant date (late filing).

Context

• These are forward-looking compensation awards (an option-type derivative and RSUs) that vest over future service periods; they do not represent immediate open‑market purchases or sales. Such grants are routine forms of equity compensation and do not by themselves indicate near-term buying or selling.